A look back and ahead at the growing trend—sparked recently by the GLP-1 trail—and new ways to harness this Rx access channel ...

Recent advancements in COPD treatments are providing patients with potential new first-line treatments. Pharmaceutical ...

Whole genome sequencing market is projected to grow significantly, driven by advancements in technology and personalized ...

Vanda Pharmaceuticals won a legal battle as a federal court overturned the FDA's rejection of Hetlioz for jet lag disorder, ...

Tonmya is the first new fibromyalgia therapy approved in over 15 years, targeting nonrestorative sleep to alleviate core ...

Novo Nordisk reduces Ozempic's price to $499/month for self-paying patients, enhancing access to essential diabetes treatment ...

NIH's new strategy emphasizes transparency, prioritizes urgent health needs, and shifts focus to domestic research and ...

Rob Abbott, CEO, ISPOR, highlights that the United States excels in areas like cancer screening and advanced medical ...

Expanded approval of Wegovy was based on results from the Phase III ESSENCE trial (NCT04822181), which demonstrated ...

How a layered approach—tapping new avenues from earned media—can go a long way in boosting the brand engagement interplay ...

What is MFN in pharma? President Trump’s executive order on drug pricing states that the United States should be treated as a ...

An examination of proactive preparedness and readiness review for future enrollment in the agency’s QMM program—now in the ...